| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.003 |